Clinical Trials

54 enrolled

Neoplasm Metastasis

NCT04802759 2026-03-16

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

316 enrolled

Neoplasm Metastasis

NCT04333706 2026-03-10

EMPOWER

65 enrolled

Neoplasm Metastasis, Neoplasms

NCT04713046 2026-03-05

Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers

24 enrolled

Neoplasm Metastasis

NCT05004116 2026-03-04

A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

77 enrolled

Neoplasm Metastasis

NCT07213817 2026-03-02

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

114 enrolled

Neoplasm Metastasis

NCT07193511 2026-02-20

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

355 enrolled

Neoplasm Metastasis

NCT07335497 2026-02-19

ASCEND

290 enrolled

Neoplasm Metastasis

NCT05039632 2026-02-06

Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies

40 enrolled

Neoplasm Metastasis

NCT04799054 2026-01-20

A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors

188 enrolled

Neoplasm Metastasis

NCT05276284 2026-01-14

TEMPLE

18 enrolled

Neoplasm Metastasis

NCT05875168 2026-01-12

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

540 enrolled

Neoplasm Metastasis

NCT06320405 2025-12-29

Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors

38 enrolled

Neoplasm Metastasis

NCT05566574 2025-12-17

A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer

49 enrolled

Neoplasm Metastasis

NCT05731271 2025-12-17

A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors

111 enrolled

Neoplasm Metastasis

NCT04021043 2025-12-03

BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers

51 enrolled 16 charts

Neoplasm Metastasis

NCT04266912 2025-11-25

Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors

23 enrolled 11 charts

Neoplasm Metastasis

NCT06311851 2025-11-25

Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases

40 enrolled

Neoplasm Metastasis, Neoplasms

NCT06184035 2025-11-20

Tumorad

90 enrolled

Neoplasm Metastasis, Neoplasms

NCT05847686 2025-11-05

Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer

55 enrolled 11 charts

Neoplasm Metastasis

NCT05384626 2025-10-30

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

840 enrolled

Neoplasm Metastasis

NCT05118789 2025-10-24

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

359 enrolled

Neoplasm Metastasis

NCT02959437 2025-10-21

Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)

70 enrolled 14 charts

Neoplasm Metastasis

NCT05898399 2025-10-15

Study of ART6043 in Advanced/Metastatic Solid Tumors Patients

220 enrolled

Neoplasm Metastasis

NCT02079740 2025-09-30

Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid Tumors

96 enrolled 30 charts

Neoplasm Metastasis

NCT04701281 2025-09-18

SYS-CAPLIOX

5 enrolled

Neoplasm Metastasis

NCT05220098 2025-08-29

First-in-Human Study of TAK-280 in Participants With Solid Tumors

69 enrolled

Neoplasm Metastasis

NCT05394103 2025-08-17

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

130 enrolled

Neoplasm Metastasis

NCT05159388 2025-07-08

A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody-Anticalin Fusion) in Patients With Solid Tumors

45 enrolled

Neoplasm Metastasis

NCT06154291 2025-06-22

FIPO23

255 enrolled

Neoplasm Metastasis

NCT04706715 2025-05-31

LAG3 PET Imaging in Advanced Solid Tumors

41 enrolled

Neoplasm Metastasis, Neoplasms

NCT04418661 2025-05-29

Safety and Efficacy Study of Vociprotafib (SAR442720) in Combination With Other Agents in Advanced Malignancies

65 enrolled 32 charts

Neoplasm Metastasis

NCT05674825 2025-05-15

MCW I-PREDICT

400 enrolled

Neoplasm Metastasis, Neoplasms

NCT06395090 2025-04-08

MK-9999-01B

Phase 1/2 Withdrawn

Neoplasm Metastasis

NCT04761198 2025-03-17

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

76 enrolled 20 charts

Neoplasm Metastasis

NCT05862324 2025-02-14

TACTIC-3

113 enrolled

Neoplasm Metastasis

NCT04574583 2025-02-03

Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT)

12 enrolled 17 charts

Neoplasm Metastasis

NCT04866134 2024-08-27

HERKULES-1

200 enrolled

Neoplasm Metastasis, Neoplasms

NCT05176665 2024-08-26

EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers

152 enrolled

Neoplasm Metastasis, Neoplasms

NCT04618393 2024-05-21

A Study of EMB-02 in Participants With Advanced Solid Tumors

47 enrolled

Neoplasm Metastasis, Neoplasms

NCT05101356 2024-05-21

A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma

77 enrolled

Adenocarcinoma, Neoplasm Metastasis

NCT04029181 2024-05-03

ImmunoPET With an Anti-CD8 Imaging Agent

47 enrolled

Neoplasm Metastasis

NCT05071183 2024-04-02

A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors

9 enrolled 17 charts

Neoplasm Metastasis

NCT05289076 2023-12-01

CRLM-Z

40 enrolled

Neoplasm Metastasis

NCT05947487 2023-07-17

CD70 Targeted CAR-T Cells in CD70 Positive Advanced/Metastatic Solid Tumors

30 enrolled

Neoplasm Metastasis

NCT05268666 2023-06-15

A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors

126 enrolled

Neoplasm Metastasis

NCT00886782 2023-04-28

A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors

11 enrolled 35 charts

Neoplasm Metastasis

NCT04800627 2022-12-27

Pevonedistat and Pembrolizumab for the Treatment of dMMR/MSI-H Metastatic or Locally Advanced Unresectable Solid Tumor

2 enrolled 4 charts

Neoplasm Metastasis

NCT04614740 2022-12-13

The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors

115 enrolled

Neoplasm Metastasis

NCT01271920 2020-12-08

Combination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With Trastuzumab

45 enrolled